Risk Factors for Polyomavirus, Cytomegalovirus, and Viruria Co-Infection for Follow-Up of Renal Transplant Patients

25 October 2022: Original Paper

Ho Trung Hieu ^1ABCDEFG* , Bui Tien Sy ^2ACEF

DOI: 10.12659/AOT.937771

Ann Transplant 2022; 27:e937771

Table 4 Cox-regression for the development of JC polyomavirus only.

	HR	(95% CI)
Hypertention	1.653	(1.053–2.596)
MMF dose (mg/day)	1.002	(1.001–1.003)
Corticoid dose (mg/day)	1.020	(1.005–1.034)
eGFR	0.988	(0.978–0.998)
Hematuria	2.032	(1.399–2.956)
Time until 1 JC detected (months)	0.884	(0.862–0.907)